Filing News

SAN DIEGO--(BUSINESS WIRE)--Jack in the Box Inc. (“Jack in the Box” or the “Company”) (NASDAQ: JACK) today announced that Rachel Ruggeri, former Executive Vice President and Chief Financial Officer of Starbucks Corporation, has been appointed to its Board of Directors (the “Board”) as an independent director. The Company also announced that Michael Murphy will retire from the Board and will not stand for reelection at the Company’s 2027 Annual Meeting of Stockholders. Ms. Ruggeri's appointment...

AUSTIN, Texas--(BUSINESS WIRE)--Empery Digital Inc. (NASDAQ: EMPD) (the “Company” or “Empery Digital”) has filed an investor presentation with the Securities and Exchange Commission in connection with its 2026 Annual Meeting of Shareholders (the “Annual Meeting”), which is scheduled to be held on October 14, 2026. The full presentation is available here. The Company’s Board of Directors said: “In just over 14 months, our Board and management team have positioned the Company to capitalize on the...

SAN FRANCISCO--(BUSINESS WIRE)--Perpetuals.com Ltd. (NASDAQ: PDC) today announced that it has filed its Annual Report on Form 20-F with the U.S. Securities and Exchange Commission, reporting financial results for the fiscal year ended April 30, 2026. Total assets reached $65.2 million as of April 30, 2026, up more than 50-fold from the prior year, reflecting the company's transformation to a fintech company that pairs proprietary AI with regulated market infrastructure to open global markets to...

BOSTON & CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Columbia Threadneedle Investments and leading private markets investment firm Hamilton Lane (Nasdaq: HLNE) today announced a strategic collaboration to deliver innovative investment solutions to the wealth channel. The collaboration brings together Columbia Threadneedle's public markets expertise, multi-asset investment capabilities and strategic distribution relationships, with Hamilton Lane's leading private markets platform, investment sourcing ca...

SAN JOSE, Calif.--(BUSINESS WIRE)--Altera Corporation today announced that its parent company has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to the proposed public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The proposed public offering remains subject to the completion of the SEC review process, as well as mar...

SANTERAMO IN COLLE, Bari, Italy--(BUSINESS WIRE)--NATUZZI ANNOUNCES THE FILING OF A REQUEST FOR REVIEW OF THE NYSE DELISTING DETERMINATION...

TORONTO--(BUSINESS WIRE)--Roots Corporation (the “Company” or “Roots”) (TSX: ROOT) today announced the filing of its management information circular (the “Circular”) and related materials for the special meeting (the “Meeting”) of holders (the “Shareholders”) of common shares (the “Shares”) of Roots to approve the previously-announced plan of arrangement under the Canada Business Corporations Act (the “Arrangement”), pursuant to which Marquee Brands LLC, through its strategic operating partner...

DENVER--(BUSINESS WIRE)--CPI Card Group Inc. (Nasdaq: PMTS) (“CPI” or the “Company”), a payments technology leader providing a comprehensive range of physical and digital payment solutions, today announced that certain stockholders affiliated with Parallel49 Equity (the “selling stockholders”) have commenced an underwritten secondary public offering of 2,337,323 shares of the Company’s common stock. In addition, the selling stockholders expect to grant the underwriters a 30-day option to purcha...

CHARLOTTE, N.C.--(BUSINESS WIRE)--Terrestrial Energy Inc. (NASDAQ: IMSR) (“Terrestrial Energy” or the “Company”), a leader in Generation IV molten salt nuclear plants supplying electricity and high-temperature industrial heat, today announced that it has submitted its Graphite Topical Report to the U.S. Nuclear Regulatory Commission (NRC). The submission supports the regulatory basis for qualifying graphite, a central component of the IMSR Core-unit, for use in commercial plant operations.“This...

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS) (the “Company” or “Gossamer”), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease, today announced that its board of directors (the “Board”) has selected a 1-for-80 reverse stock split of the Company’s common stock and a proportionate reduction in the number...